NCT06808321

Benidipine in Hypertensive and/or Chronic Coronary Syndrome Patients

Evaluation of Clinical Outcomes of Benidipine in Hypertensive and/or Chronic Coronary Syndrome Patients in the Turkish Population

• Status: Enrolling By Invitation
• Phase: —
• Study type: Observational
• Enrollment: 800 (estimated)
• Sponsor: The Society of Prevention and Awareness of Cardiovascular Diseases · Academic / Other
• Sex: All
• Age: 18 Years – 80 Years
• Healthy volunteers: —

Summary

Evaluation of the clinical outcomes of Benidipine initiated by physician's preference in patients with hypertension and/or angina pectoris (chronic coronary syndrome) presenting to cardiology outpatient clinics in Turkey.

Detailed description

* Benidipine is a dihydropyridine calcium channel blocker used in the treatment of hypertension and angina pectoris. There are currently no large-scale observational studies in these patient groups in Turkey. * There is no record of benidipine in clinicaltrials.gov, which is an important database especially for the registration of drug and interventional studies. * Therefore, it will be extremely important to include this study in clinicaltrials.gov and to evaluate the clinical efficacy of Bendipine in patients with hypertensive and/or angina pectoris in 7 geographical regions of Turkey.

Conditions

• Chronic Coronary Syndrome
• Hypertension
• Angina Pectoris

Interventions

Type	Name	Description
DRUG	Benidipine Hydrochloride	The safety and efficacy of a dihydropyridine calcium channel blocker for the treatment of high blood pressure and/or angina pectoris

Timeline

• Start date: 2025-03-01
• Primary completion: 2026-01-01
• Completion: 2026-06-01
• First posted: 2025-02-05
• Last updated: 2025-09-09

Locations

1 site across 1 country: Turkey (Türkiye)